How much funding has InCarey raised?

InCarey has raised $45.0M in total funding, most recently a Series B round.

Who are InCarey's investors?

InCarey's investors include Long Hill Capital, Northern Light Ventures.

Where is InCarey headquartered?

InCarey is headquartered in Shanghai, China.

What industry is InCarey in?

InCarey operates in Chronic Disease Management, Digital Health, Healthcare.

InCarey

Closed

Shanghai, China · Founded 2011 · $45.0M raised

Chronic Disease Management

Digital Health

Healthcare

Headquarters: Shanghai
Founded: 2011
Business Model: B2B2C
Website: incarey.cn

Total Funding: $45.0M
Last Round: $30.0M Series BSep 2020
Rounds: 2

About

InCarey is a China-based digital healthcare service platform offering comprehensive disease management services for patients with chronic and specialty diseases including oncology, central nervous system disorders, rheumatic bone diseases, and congenital heart diseases. The cloud-based platform enables one-on-one doctor-patient interaction, professional disease management services, nutrition follow-up management for postoperative patients, and an internet retail platform allowing patients to receive medicines for major diseases through e-commerce. InCarey raised a $30 million Series B+ round in September 2020 led by Long Hill Capital.

Summary

InCarey is a Chronic Disease Management company based in Shanghai, China, founded in 2011. It has raised $45.0M in total across 2 rounds, most recently a $30.0M Series B round in Sep 2020. Investors include Long Hill Capital and Northern Light Ventures.